Coronavirus Drug Discovery - Volume 3: Druggable Targets and In Silico Update (Paperback)

Coronavirus Drug Discovery, Volume Three: Druggable Targets and In Silico Update presents comprehensive information on drug discovery against COVID-19. Chapters in Part One of this volume describe the various druggable targets and associated signaling pathways for effective targeting of SARS-CoV-2. In Part Two, chapters discuss the various computational approaches and in silico studies against SARS-CoV-2. Written by global team of experts, this book is an excellent resource that will be extremely useful to drug developers, medicinal chemists, pharmaceutical companies in R&D, research institutes in both academia and industry, and the National Library of Medicines and Health. In addition, agencies such as the National Institutes of Health, Centers for Disease Control and Prevention, World Health Organization, European Medicines Agency, the US Food and Drug Administration, and all others involved in drug discovery against COVID-19 will find this book useful.

General

Imprint:	Elsevier - Health Sciences Division
Country of origin:	United States
Series:	Drug Discovery Update
Release date:	July 2022
First published:	2022
Editors:	Chukwuebuka Egbuna
Dimensions:	229 x 152mm (L x W)
Format:	Paperback
Pages:	406
ISBN-13:	978-0-323-95578-2
Categories:	Books > Business & Economics > Industry & industrial studies > Manufacturing industries > Pharmaceutical industries Books > Medicine > Other branches of medicine > Pharmacology > General Books > Science & Mathematics > Chemistry > Organic chemistry > General
LSN:	0-323-95578-9
Barcode:	9780323955782

Is the information for this product incomplete, wrong or inappropriate? Let us know about it.

Does this product have an incorrect or missing image? Send us a new image.

Is this product missing categories? Add more categories.

Review This Product

No reviews yet - be the first to create one!